for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Catalyst Biosciences Inc

CBIO.OQ

Latest Trade

5.36USD

Change

0.02(+0.37%)

Volume

8,493

Today's Range

5.36

 - 

5.44

52 Week Range

4.52

 - 

11.28

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Catalyst Biosciences Q3 Loss Per Share $1.06

Nov 7 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES REPORTS THIRD QUARTER 2019 OPERATING & FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE.Q3 LOSS PER SHARE $1.06.Q3 EARNINGS PER SHARE ESTIMATE $-1.07 -- REFINITIV IBES DATA.

Catalyst Biosciences Says Cash, Cash Equivalents And Short-Term Investments, As Of Sept 30 Were $85 Mln

Nov 7 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES INC - CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS, AS OF SEPTEMBER 30, 2019 WERE $85.0 MILLION.

Catalyst Biosciences Announces Transition Of CFO

Aug 29 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES ANNOUNCES TRANSITION OF CHIEF FINANCIAL OFFICER.CATALYST BIOSCIENCES INC - CHIEF FINANCIAL OFFICER, FLETCHER PAYNE, WILL BE STEPPING DOWN FROM COMPANY.CATALYST BIOSCIENCES INC - COMPANY IS INITIATING A SEARCH FOR A SUCCESSOR..

Catalyst Biosciences Reports Q2 Loss Per Share $1.15

Aug 1 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES REPORTS SECOND QUARTER 2019 OPERATING & FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE.Q2 LOSS PER SHARE $1.15.Q2 EARNINGS PER SHARE ESTIMATE $-1.11 -- REFINITIV IBES DATA.QTRLY CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $94.0 MILLION VERSUS 124. 0 MILLION SEQUENTIALLY.

Julian Singer Reports A 3.1% Stake In Catalyst Biosciences As Of July 22

July 23 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::JULIAN SINGER REPORTS A 3.1% STAKE IN CATALYST BIOSCIENCES INC AS OF JULY 22 - SEC FILING.JULIAN SINGER SAYS DELIVERED LETTER TO CATALYST BIOSCIENCES' BOARD.JULIAN SINGER SAYS BOARD SHOULD CONSIDER TAKING STEPS TO REMEDIATE SHAREHOLDER CONCERNS, INCLUDING BY ADDING SHAREHOLDER REPRESENTATION ON CATALYST BIOSCIENCES' BOARD.JULIAN SINGER SAYS BOARD SHOULD CONSIDER TAKING STEPS TO REMEDIATE SHAREHOLDER CONCERNS, INCLUDING RETAINING INVESTMENT BANK TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES.JULIAN SINGER SAYS BELIEF BOARD SHOULD WORK HIM BY VOLUNTARILY ADDING TWO SHAREHOLDER REPRESENTATIVES TO CATALYST BIOSCIENCES' BOARD.

Catalyst Biosciences Says Co Meets Primary Endpoint In Phase 2 Trial Of Subcutaneous MarzAA

July 8 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES MEETS THE PRIMARY ENDPOINT OF REDUCTION IN ANNUALIZED BLEEDING RATE IN THE PHASE 2 TRIAL OF SUBCUTANEOUS MARZEPTACOG ALFA (ACTIVATED) IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS.SUBCUTANEOUS MARZAA (FVIIA) PROPHYLAXIS REDUCED ANNUALIZED BLEEDING RATE BY MORE THAN 90% COMPARED WITH PRETREATMENT.

Mangrove Partners Reports 5.0% Passive Stake In Catalyst Biosciences As Of May 10

May 14 (Reuters) - Mangrove Partners::MANGROVE PARTNERS REPORTS 5.0% PASSIVE STAKE IN CATALYST BIOSCIENCES INC AS OF MAY 10 - SEC FILING.

Catalyst Biosciences Reports Q1 Loss Per Share $1.26

May 2 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES REPORTS FIRST QUARTER 2019 OPERATING & FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE.Q1 LOSS PER SHARE $1.26.CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF MARCH 31, 2019 WERE $105.3 MILLION.

Catalyst Biosciences Q4 Loss Per Share $0.91

March 7 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2018 OPERATING & FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE.Q4 LOSS PER SHARE $0.91.CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS, AS OF DECEMBER 31, 2018 WERE $120.1 MILLION.

Catalyst Biosciences Inc files for mixed shelf of up to $200 million – SEC Filing

Dec 21 (Reuters) - Catalyst Biosciences Inc <CBIO.O>::CATALYST BIOSCIENCES INC FILES FOR MIXED SHELF OF UP TO $200 MILLION – SEC FILING.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up